如何解释临床医生需要治疗的数量
Nicholas C Chesnaye1,2, Alberto Ortiz3, Merel van Diepen4
1ERA Registry, Amsterdam UMC location University of Amsterdam, Medical Informatics, Amsterdam, Netherlands.
概括
需要治疗的数量 (NNT) 有助于评估干预的有效性. 了解NNT,伤害所需的数量 (NNH) 和被帮助或伤害的可能性 (LHH) 对于临床决策至关重要.
科学领域:
- 医学统计
- 临床流行病学
- 基于证据的医学
背景情况:
- 需要治疗的数量 (NNT) 是评估医疗干预有效性的关键指标.
- 有信息的临床决策依赖于对治疗效果的准确解释.
研究的目的:
- 用二进制和时间到事件数据阐明NNT的计算.
- 引入和定义相关指标:需要伤害的数量 (NNH) 和被帮助或伤害的可能性 (LHH).
- 提供关于NNT在临床研究中的正确应用和解释的指导.
主要方法:
- 对二进制结果的NNT计算的解释.
- 时间到事件数据的NNT计算的解释.
- 讨论常见的解释陷和最佳实践.
主要成果:
- 在不同数据类型中提供NNT计算的明确方法.
- 定义并将NNH和LHH与NNT结合在一起.
- 突出了NNT准确解释的关键因素,包括基线风险,时间和置信区间.
结论:
- 准确的NNT计算和解释对于基于证据的医学实践至关重要.
- 了解NNT,NNH和LHH有助于评估干预的有效性和患者安全性.
- 遵守NNT应用指南可确保可靠的临床决策.
相关概念视频
Therapeutic Index
5.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Hazard Ratio
243
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
243
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.4K
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
Renal Failure: Dose Adjustments
153
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
153


